查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1696296

全球微生物培養市場 - 2025 至 2033 年

Global Microbiology Culture Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球微生物培養市場規模達到 203.8 億美元，預計到 2033 年將達到 402 億美元，2025-2033 年預測期內的複合年成長率為 7.2%。

微生物培養是一種培養微生物以確定其身份、樣本中的豐度或兩者的方法。它是微生物學的主要診斷方法之一。培養微生物需要適當的物理環境，包括受控的 pH 值、大氣氣體、溫度和壓力。微生物培養基製備包括混合營養物質、緩衝劑、滲透平衡調節劑和選擇性抑制劑或指示劑，以產生支持微生物生長和分化的瓊脂或肉湯。該過程是微生物測試中監測腐敗和致病微生物的常規任務。

最常見的方法是使用含有瓊脂基生長培養基的培養皿，通常在培養箱中。另一種方法是液體培養，細菌懸浮在液體營養培養基中生長，通常會搖晃以保持均勻。

市場動態：

促進因素與約束因素

傳染病發生率上升

隨著細菌、病毒和真菌感染（如結核病、登革熱、肺炎、血流感染和醫院內感染）的發病率不斷增加，對微生物培養物的需求也日益增加，以檢測和研究這些病原體。例如，根據世界衛生組織 2023 年的數據，全球約有 1,080 萬人患有結核病 (TB)，其中包括 600 萬名男性、360 萬名女性和 130 萬名兒童。結核病存在於所有國家和年齡人口中，並且可能再次成為全球單一傳染源導致死亡的主要原因。

隨著結核病的廣泛流行和抗藥性結核病菌株的威脅日益增加，對微生物培養技術的需求預計將成長，因為它們對於準確診斷、藥物敏感性測試和治療監測在應對這一持續的公共衛生挑戰中仍然至關重要。對早期發現和控制疫情的需求日益成長，進一步加強了微生物培養市場。

嚴格的文化媒體生產規範架構

培養基生產的嚴格監管框架可能會對微生物培養市場造成重大限制，因為製造商必須遵守 FDA、EMA 和 ISO 等監管機構制定的嚴格品質、安全和性能標準。

這些法規要求進行大量的驗證、無菌測試和品質控制程序，從而增加了新培養基產品的生產成本和上市時間。這些成本可能會對正在創新先進微生物系統或具有不同成分的微生物培養物的眾多市場參與者造成障礙。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按產品類型分類
  • 按文化類型分類
  • 一致性的片段
  • 按應用程式截取的程式碼片段
  • 按地區分類

第 3 章：動態

  • 影響因素
    • 驅動程式
      • 傳染病發生率上升
      • 增加微生物學和生命科學領域的研發投入
    • 限制
      • 嚴格的文化媒體生產規範架構
      • 污染和結果不一致的風險
    • 機會
      • 難培養微生物的創新培養基潛力
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 5 章：微生物培養市場（依產品類型）

  • 文化設備
    • 生物反應器
      • 生物反應器設備
      • 測量儀器
      • PH 感測器
      • 溶氧感知器
      • 溫度感測器
      • 其他
      • 分析設備
      • 細胞計數器
      • 光譜儀
      • 其他
      • 滅菌設備
      • 孵化器
      • 其他
  • 文化補編
  • 測量儀器
    • PH 感測器
    • 溫度感測器
    • 溶氧感知器
    • 其他
  • 文化儀器
    • 培養皿
    • 線圈與針
    • 微量移液器
    • 離心機
    • 其他
  • 分析設備
    • 細胞計數器
    • 光譜儀
    • 其他

第 6 章：微生物培養市場（依培養類型）

  • 真核培養
  • 細菌培養

第 7 章：微生物培養市場（按一致性）

  • 液體培養基
  • 固體培養基
  • 半固體培養基

第 8 章：微生物培養市場（按應用）

  • 藥品
  • 食品飲料業
  • 其他
  • 水質檢測
  • 化妝品

第 9 章：微生物培養市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第 11 章：公司簡介

  • Danaher (Cytiva)
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • BD
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Eiken Chemical co. Lti.
  • HiMedia Laboratories Pvt. Ltd
  • Kerry Group Plc
  • BioMerieux SA
  • Mettler Toledo
  • Yokogawa Electric Corporation
  • Conda Laboratories SA
  • SATAKE MultiMix Corporation
  • BE MARUBISHI CO., LTD.
  • ABLE Corporation & Biott Corporation

第 12 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章：附錄

簡介目錄
Product Code: PH4443

The global microbiology culture market reached US$ 20.38 billion in 2024 and is expected to reach US$ 40.20 billion by 2033, growing at a CAGR of 7.2% during the forecast period 2025-2033.

A microbiology culture, or microbial culture, is a method of growing a microbial organism to determine its identity, its abundance in a sample, or both. It is one of the primary diagnostic methods in microbiology. Growing a microbial culture requires an appropriate physical environment with controlled pH, atmospheric gases, temperature, and pressure. Microbial culture media preparation involves mixing nutrients, buffering agents, osmotic balance regulators, and selective inhibitors or indicators to create agar or broth that supports microbial growth and differentiation. This process is a routine task in microbiological testing for monitoring spoilage and pathogenic microbes.

The most common method is using Petri dishes with agar-based growth medium, typically in an incubator. Another method is liquid culture, where bacteria are grown suspended in a liquid nutrient medium, often shaken to maintain uniformity.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Infectious Diseases

With the increasing incidence of bacterial, viral, and fungal infections, such as tuberculosis, dengue, pneumonia, bloodstream infections, and hospital-acquired infections, there is a growing need for microbial cultures to detect and study these pathogens. For instance, according to the World Health Organization in 2023, an estimated 10.8 million people worldwide fell ill with tuberculosis (TB), including 6.0 million men, 3.6 million women, and 1.3 million children. TB is present across all countries and age groups, and it has likely returned as the leading cause of death from a single infectious agent globally.

With its widespread prevalence and the increasing threat of drug-resistant TB strains, the demand for microbiological culture techniques is expected to grow, as they remain essential for accurate diagnosis, drug susceptibility testing, and treatment monitoring in combating this persistent public health challenge. The growing need for early detection and control of the outbreaks further strengthens the microbiology culture market.

Stringent Regulatory Framework for Culture Media Production

Stringent regulatory framework for culture media production could be a significant restraint for the microbiology culture market, as manufacturers must comply with strict quality, safety, and performance standards set by regulatory bodies like the FDA, EMA, and ISO.

These regulations require extensive validation, sterility testing, and quality control procedures, increasing production costs and time-to-market for new culture media products. These costs could be barrier to several market players who are innovating advanced microbiology systems or microbiology cultures with different compositions.

Segment Analysis

The global microbiology culture market is segmented based on the product type, culture type, consistency, application, and region.

Culture equipment in the product type segment is expected to dominate the microbiology culture market

Culture equipment plays a crucial role in the microbiology culture market by enabling precise microbial growth, monitoring, and analysis across various industries, including pharmaceuticals, clinical diagnostics, and food safety. Culture equipment comprises incubators, bioreactors, analytical devices, sterilization equipment, and others. Bioreactors are essential in microbiology culture, enabling the controlled growth of cells and microorganisms for drug production, vaccine development, and research. Sterilization equipment also plays a critical role in the microbiological culture market, as it ensures the prevention of contamination and maintains the integrity of cell cultures, which is essential for accurate research and experimentation.

Mergers and acquisitions (M&A) and collaborations play a crucial role in driving growth, innovation, and market expansion in the culture incubator and microbiology culture equipment sectors. For instance, in January 2023, Culture Biosciences and Cytiva teamed up to enhance upstream bioprocessing by integrating Culture's 250mL and 5L single-use bioreactors into Cytiva's Bioreactor Scaler tool. The 250mL bioreactors, mounted in mobile cart modules of four, support mammalian cell culture and microbial fermentation.

Geographical Analysis

North America is expected to dominate the microbiology culture market

North America, particularly the United States and Canada, holds a dominant position in the global microbiology culture market. The region's robust healthcare systems, including hospitals, clinics, and diagnostic laboratories, fuel the need for microbiology culture products.

Moreover, the rising prevalence of infectious diseases and the increasing focus on antimicrobial resistance further drive the market growth in the region. For instance, the Centers for Disease Control and Prevention (CDC) estimates that Salmonella causes approximately 1.35 million infections annually in the United States. This widespread bacterial infection is one of the country's most common causes of foodborne illness. It leads to about 26,500 hospitalizations and 420 deaths each year.

With this high incidence of Salmonella infections, there is a higher demand for microbiology cultures to detect pathogens in food, water, and clinical samples. Laboratories use microbiology culture media to grow and identify harmful microorganisms, leading to more sales of specialized culture products and testing kits.

The rising adoption of personalized medicine and microbial-based therapeutics is driving market expansion by enabling targeted treatments tailored to individual patient needs. Thus, the above factors are expected to drive the region's growth by solidifying the region's growth in the global microbiology culture market.

Competitive Landscape

The global market players in the microbiology culture market are Danaher (Cytiva), BD, Merck KGaA, Thermo Fisher Scientific Inc., Sartorius AG, Eiken Chemical co. Lti., HiMedia Laboratories Pvt. Ltd, Kerry Group Plc, BioMerieux S.A., Mettler Toledo, Yokogawa Electric Corporation, Conda Laboratories S.A, SATAKE MultiMix Corporation, B.E. MARUBISHI CO., LTD., and ABLE Corporation & Biott Corporation among others.

Key Developments

  • In November 2024, Dedalus Group and Ibex Medical Analytics have launched a fully integrated End-to-End AI-powered Digital Pathology Solution for cancer diagnosis, now commercially available in major European markets. The solution sets a new standard for anatomic pathology lab digitization by seamlessly integrating Ibex's GalenTM platform into Dedalus' comprehensive Digital Pathology (DP) Solution.
  • In September 2024, Roche has expanded its digital pathology open environment with over 20 AI algorithms from eight new collaborators, aiming to support pathologists and scientists in cancer research and diagnosis by leveraging advanced AI technology

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global microbiology culture market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Culture Type
  • 2.5. Snippet by Consistency
  • 2.6. Snippet by Application
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Infectious Diseases
      • 3.1.1.2. Increasing R&D Investments in Microbiology and Life Sciences
    • 3.1.2. Restraints
      • 3.1.2.1. Stringent Regulatory Framework for Culture Media Production
      • 3.1.2.2. Risk of Contamination and Inconsistent Results
    • 3.1.3. Opportunity
      • 3.1.3.1. Potential for Innovative Culture Media for Fastidious Microorganisms
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Microbiology Culture Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Culture Equipment*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Bioreactors
      • 5.2.3.1. Bioreactor Devices
      • 5.2.3.2. Measuring Instruments
      • 5.2.3.2.1. PH Sensors
      • 5.2.3.2.2. Dissolved Oxygen Sensors
      • 5.2.3.2.3. Temperature Sensors
      • 5.2.3.2.4. Others
      • 5.2.3.3. Analytical Devices
      • 5.2.3.3.1. Cell Counters
      • 5.2.3.3.2. Spectrometers
      • 5.2.3.3.3. Others
      • 5.2.3.4. Sterilization Equipment
      • 5.2.3.5. Incubators
      • 5.2.3.6. Others
  • 5.3. Culture Supplements
  • 5.4. Measuring Instruments
    • 5.4.1. PH Sensors
    • 5.4.2. Temperature Sensors
    • 5.4.3. Dissolved Oxygen Sensors
    • 5.4.4. Others
  • 5.5. Culture Instruments
    • 5.5.1. Petri Dishes
    • 5.5.2. Loops & Needles
    • 5.5.3. Micropipettes
    • 5.5.4. Centrifuge
    • 5.5.5. Others
  • 5.6. Analytical Devices
    • 5.6.1. Cell Counters
    • 5.6.2. Spectrometers
    • 5.6.3. Others

6. Microbiology Culture Market, By Culture Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 6.1.2. Market Attractiveness Index, By Culture Type
  • 6.2. Eukaryotic Culture*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Bacterial Culture

7. Microbiology Culture Market, By Consistency

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 7.1.2. Market Attractiveness Index, By Consistency
  • 7.2. Liquid Media*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Solid Culture Media
  • 7.4. Semi-solid Media

8. Microbiology Culture Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Pharmaceuticals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Food & Beverage Industry
  • 8.4. Others
  • 8.5. Water Testing
  • 8.6. Cosmetics

9. Microbiology Culture Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Mexico
      • 9.4.7.2. Brazil
      • 9.4.7.3. Argentina
      • 9.4.7.4. Rest of Latin America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Danaher (Cytiva)*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. BD
  • 11.3. Merck KGaA
  • 11.4. Thermo Fisher Scientific Inc.
  • 11.5. Sartorius AG
  • 11.6. Eiken Chemical co. Lti.
  • 11.7. HiMedia Laboratories Pvt. Ltd
  • 11.8. Kerry Group Plc
  • 11.9. BioMerieux S.A.
  • 11.10. Mettler Toledo
  • 11.11. Yokogawa Electric Corporation
  • 11.12. Conda Laboratories S.A
  • 11.13. SATAKE MultiMix Corporation
  • 11.14. B.E. MARUBISHI CO., LTD.
  • 11.15. ABLE Corporation & Biott Corporation

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us